欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

全球手性技术市场报告(2012-2016年)

Global Chiral Technology Market(2012-2016)
加工时间:2013-09-27 信息来源:EMIS 索取原文[48 页]
关键词:手性分子;手性技术;手性药物;制药;外消旋体
摘 要:The phenomenon by which molecules do not superimpose with their mirror images is termed as chirality, and such molecules are called chiral molecules. The importance of chiral drugs has long been recognized by pharmaceutical companies as a means to mitigate side effects in patients. Many drugs that possess chiral characteristics are administered as racemates despite the fact that the optical isomers of racemic drugs can exhibit different pharmacological profiles in the human body. Chiral technologies are used to synthesize, analyze, and separate out the enantiomers from a racemic mixture. In particular, they help in the development of the enantiopure form of a drug to produce the required effect.The growth of the Global Chiral Technology market is driven by several factors. Governmental regulations that support the use of chiral technology constitute a major driver in this market. Healthcare authorities in many countries have introduced guidelines and policies that provide incentives for investments made in developing single enantiomer drugs. Further, there is a growing demand for enantiopure drugs.
目 录:01. Executive Summary

02. Scope of the Report

02.1 Market Overview

02.2 Product Offerings

03. Market Research Methodology

03.1 Market Research Process

 03.2 Research Design

03.3 Research Methodology

04. List of Abbreviations

05. Introduction

06. Market Landscape

 06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Technology

 07.1.1 Traditional Technology

07.1.2 2. Asymmetric Technology

07.1.3 3. Biological

07.2 Global Traditional Chiral Technology Market

07.2.1 Market Size and Forecast

07.3 Global Asymmetric Chiral Technology Market

07.3.1 Market Size and Forecast

07.4 Global Biological Chiral Technology Market

07.4.1 Market Size and Forecast

08. Geographical Segmentation

08.1 Impact of Outsourcing Drug Development Activities

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

16.1 Competitive Scenario

16.2 Other Vendors

17. Key Vendor Analysis

17.1 BASF SE

17.1.1 Business Overview

17.1.2 Business Segmentation

17.1.3 Key Information

17.1.4 SWOT Analysis

17.2 Daicel Corp

17.2.1 Business Overview

17.2.2 Business Segmentation

17.2.3 Key Information

17.2.4 SWOT Analysis

17.3 Royal DSM N.V

17.3.1 Business Overview

17.3.2 Business Segmentation

17.3.3 Key Information

17.3.4 SWOT analysis

18. Other Reports in this Series

© 2016 武汉世讯达文化传播有限责任公司 版权所有
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服